Triptorelin is a synthetic analog of gonadotropin-releasing hormone (GnRH) used for the treatment of prostate cancer, endometriosis, and precocious puberty. It is available in various dosage forms, including injection, implant, and powder for reconstitution. The triptorelin market is expected to grow at a significant rate due to increasing prevalence of prostate cancer and other related diseases, the rise in the geriatric population, and the increasing demand for advanced treatment options.
Market Size
The triptorelin market size was valued at USD 366.6 million in 2020 and is expected to grow at a CAGR of 6.1% during the forecast period from 2021 to 2028. The increasing prevalence of prostate cancer and other related diseases, rising geriatric population, and increasing demand for advanced treatment options are the key factors driving the growth of the market. Additionally, the availability of various dosage forms, including injection, implant, and powder for reconstitution, is also contributing to the growth of the market.
Market Share
The market share of triptorelin is dominated by the injectable dosage form due to its widespread availability and ease of administration. The implant and powder for reconstitution dosage forms are expected to witness significant growth during the forecast period due to the increasing demand for long-acting formulations and the availability of patient-friendly options. Additionally, the market share of triptorelin is dominated by North America due to the high prevalence of prostate cancer and other related diseases and the availability of advanced healthcare infrastructure.
Trends Analysis
The increasing prevalence of prostate cancer and other related diseases is one of the major trends driving the growth of the triptorelin market. According to the American Cancer Society, prostate cancer is the second most common cancer among men, with over 248,530 new cases expected to be diagnosed in 2021. The rise in the geriatric population is also contributing to the growth of the market as the elderly are more susceptible to prostate cancer and other related diseases. Additionally, the increasing demand for advanced treatment options is driving the growth of the market as patients are looking for more effective and patient-friendly treatment options.
The availability of various dosage forms, including injection, implant, and powder for reconstitution, is another trend driving the growth of the market. The injectable dosage form is widely available and is easy to administer, making it the preferred choice for many patients. The implant and powder for reconstitution dosage forms are expected to witness significant growth during the forecast period due to the increasing demand for long-acting formulations and the availability of patient-friendly options.
The increasing focus on research and development activities is also a significant trend driving the growth of the triptorelin market. Pharmaceutical companies are investing heavily in R&D activities to develop new and improved formulations of triptorelin with enhanced efficacy and fewer side effects. For instance, in 2021, Ipsen Pharma received approval from the US FDA for its Triptodur (triptorelin) injection for the treatment of pediatric patients with central precocious puberty.
Conclusion
The triptorelin market is expected to grow at a significant rate due to increasing prevalence of prostate cancer and other related diseases, the rise in the geriatric population, and the increasing demand for advanced treatment options. The availability of various dosage forms, including injection, implant, and powder for reconstitution, is also contributing to the growth of the market. Additionally, the increasing focus on research and development activities is driving the growth of the market as pharmaceutical companies are developing new and improved formulations of triptorelin with enhanced efficacy and fewer side effects.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Knox Market Research journalist was involved in the writing and production of this article.
